The impact of the ATTC Network has been featured in the 29th Annual Congress of the ESGCT special issue of Human Gene Therapy (September 2022).

Authored by Michael Whitaker, Steering Board Chair of Northern Alliance ATTC, the publication considers the impact of the three centres and how the ATTC Network could be used as an exemplar model for other healthcare systems which are moving towards the adoption of advanced therapies. Read the full article here: